News
EQS-News: Heidelberg Pharma announces financial figures and reports on successful business performance in 2024
Poxel Announces Positive Results from a Preclinical Study for PXL065, a Proprietary Deuterium-Stabilized R-Stereoisomer of Pioglitazone, in Hypertrophic Cardiomyopathy
Regulatory News:
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
Inogen To Present at 24th Annual Needham Virtual Healthcare Conference
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced management will participate in the 24th Annual
EQS-News: Eckert & Ziegler and AtomVie Global Radiopharma Sign a Global Agreement for Lutetium-177 Supply
GenSight Biologics Confirms Definitive Full-Year 2024 Consolidated Financial Results Are in Line with Estimates
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal
EQS-News: Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 1.80 per share
EQS-News: MEDICLIN invites you to the 2025 virtual press conference on the financial statements for the year 2024
Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski
Agilent Technologies Inc. (NYSE: A) today announced that Columbia University has received an Agilent Research Catalyst (ARC) Award on behalf of Dr. Pawel Muranski, an internationally recognized
Vistagen to Present at the 2025 Anxiety and Depression Association Conference
Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product
Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care
DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the "Dexcom State of Type 2 Report: Access and Attitudes Across
Pfizer Invites Public to View and Listen to Webcast of April 29 Conference Call with Analysts
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on Tuesday, April 29, 2025. The
EQS-News: Results of the 2025 Annual General Meeting for the 2023/24 financial year of BRAIN Biotech AG
STAAR Surgical Announces Realignment of Leadership Structure
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the following changes
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported recent business highlights and fourth quarter and full year 2024 financial results.
“I am pleased with
Savara to Present New Data From the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society International Conference 2025
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced the acceptance of two abstracts for poster presentation at
GenSight Biologics Announces LUMEVOQ® Scientific Updates at NANOS 2025
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal
Sensorion Reports Full-Year 2024 Results, Provides Corporate Update and Announces Availability of Full-Year Report
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss
Xencor Appoints Todd Simpson to Board of Directors
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced the appointment of Todd
Sir Ivan Releases "Love Is The Piece"
The Peace Anthem of the 21st Century
MIAMI, FLORIDA / ACCESS Newswire / January 23, 2026 /Electronic Dance Music (EDM) recording artist, Sir Ivan, has co-written and recorded a peace song
GA-ASI and Barzan Holdings Sign MOU
Companies Will Collaborate on the Development of Advanced Battle Management
DOHA, QA / ACCESS Newswire / January 19, 2026 / General Atomics Aeronautical Systems, Inc. (GA-ASI) -- the world
Vanguard Mining to Launch Phase 1 Exploration at Nucleon Uranium Project Along the PLS–Arrow Discovery Corridor
Vancouver, BC – January 13, 2026 – Vanguard Mining Corp. ("Vanguard" or the "Company") (CSE: UUU | OTC: UUUFF | Frankfurt: SL51) is pleased to announce the commencement of its Phase 1
Vanguard Mining startet Phase-1-Exploration im Uranprojekt Nucleon entlang des Entdeckungskorridors PLS–Arrow
Vancouver, BC – 13. Januar 2026 / IRW-Press / Vanguard Mining Corp. („Vanguard“ oder das „Unternehmen“) (CSE: UUU | OTC: UUUFF | Frankfurt: SL51) freut sich, den Start seines
Market Logic Announces Technology Partnership with Zappi to Accelerate Innovation with AI
BERLIN, DE / ACCESS Newswire / January 8, 2026 / Market Logic Software is excited to announce a technology partnership with Zappi designed to help leading brands develop, refine, and test new
Datavault AI and The Dream Bowl to Set New Benchmark in Sports Innovation with World’s First Tokenized Autograph Session, Featuring Current and Future NFL Stars - Live on ESPN+
30 former NFL star players from different NFL Teams will autograph on-site up to 3,000 The Dream Bowl memorabilia items such as helmets, footballs, jerseys, and live-autographs by Notable
Datavault AI und The Dream Bowl setzen neue Maßstäbe in der Sportinnovation mit der weltweit ersten tokenisierten Autogrammstunde mit aktuellen und zukünftigen NFL-Stars – live auf ESPN+.
30 ehemalige NFL-Spieler aus verschiedenen NFL-Teams werden vor Ort bis zu 3.000 Erinnerungsstücke des Dream Bowl wie Helme, Fußbälle, Trikots und Live-Autogramme von Notable Live signieren.